CT
Clearstead Trust’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.96K | Hold |
102
| – | – | ﹤0.01% | 750 |
|
|
2025
Q1 | $3.47K | Hold |
102
| – | – | ﹤0.01% | 681 |
|
|
2024
Q4 | $4.02K | Buy |
+102
| New | +$4.02K | ﹤0.01% | 397 |
|
|
2024
Q3 | – | Sell |
-115
| Closed | -$6.21K | – | 420 |
|
|
2024
Q2 | $6.21K | Hold |
115
| – | – | ﹤0.01% | 378 |
|
|
2024
Q1 | $7.84K | Hold |
115
| – | – | ﹤0.01% | 362 |
|
|
2023
Q4 | $7.2K | Hold |
115
| – | – | ﹤0.01% | 354 |
|
|
2023
Q3 | $5.22K | Buy |
+115
| New | +$5.22K | ﹤0.01% | 381 |
|
|
2022
Q4 | – | Sell |
-170
| Closed | -$11K | – | 384 |
|
|
2022
Q3 | $11K | Hold |
170
| – | – | ﹤0.01% | 282 |
|
|
2022
Q2 | $10K | Hold |
170
| – | – | 0.01% | 149 |
|
|
2022
Q1 | $11K | Buy |
+170
| New | +$11K | 0.01% | 155 |
|
|
2020
Q1 | – | Sell |
-135
| Closed | -$8K | – | 177 |
|
|
2019
Q4 | $8K | Buy |
+135
| New | +$8K | 0.01% | 160 |
|